VORICONAZOLE-GX voriconazole 200mg tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

voriconazole, Quantity: 200 mg

제공처:

Medis Pharma Pty Ltd

INN (International Name):

Voriconazole

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: lactose monohydrate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; povidone; titanium dioxide; hypromellose; triacetin; macrogol 3350

관리 경로:

Oral

패키지 단위:

30, 28, 14, 2, 56, 50, 100, 10, 20

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

VORICONAZOLE-GX is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

제품 요약:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2015-02-02